Schwab Andrew J. sold SKYE
August 20, 2026 · Form 4 insider transaction
Schwab Andrew J. sold 6,495 shares of Skye Bioscience, Inc. at $0.32 per share, a transaction worth $2.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,495
Price
$0.32
Total value
$2.1K
InsiderSchwab Andrew J.
RoleDirector, 10% owner
CompanySkye Bioscience, Inc. (SKYE)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 20, 2026
Filing dateAugust 20, 2026
Shares owned after7,850,155
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.